A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

Inclusion Criteria

• •Subject is a male or non-pregnant female age 18 years or older at the time of surgery;
• •Subject is willing and able to give written informed consent and comply with the requirements of this Clinical Investigation Plan;
• •Subject is intended to be, treated with the Tibial Nail of the T2 Alpha Tibia Nailing System in accordance with the following legally cleared/ approved Indications for Use:
• •Indications for Use approved In United States and Canada include:
• •Open and closed tibial fractures
• •Pseudoarthrosis and correction osteotomy
• •Pathologic fractures, impending pathologic fractures and tumor resections
• •Fractures involving osteopenic and osteoporotic bone
• •Nonunions and malunions